Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder.

Millett CE, Perez-Rodriguez M, Shanahan M, Larsen E, Yamamoto HS, Bukowski C, Fichorova R, Burdick KE.

Mol Psychiatry. 2019 Nov 19. doi: 10.1038/s41380-019-0591-1. [Epub ahead of print]

PMID:
31740754
2.

Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.

Fortner RT, Schock H, Le Cornet C, Hüsing A, Vitonis AF, Johnson TS, Fichorova RN, Fashemi T, Yamamoto HS, Tjønneland A, Hansen L, Overvad K, Boutron-Ruault MC, Kvaskoff M, Severi G, Boeing H, Trichopoulou A, Papatesta EM, La Vecchia C, Palli D, Sieri S, Tumino R, Sacerdote C, Mattiello A, Onland-Moret NC, Peeters PH, Bueno-de-Mesquita HBA, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Navarro C, Ardanaz E, Larrañaga N, Nodin B, Jirström K, Idahl A, Lundin E, Khaw KT, Travis RC, Gunter M, Johansson M, Dossus L, Merritt MA, Riboli E, Terry KL, Cramer DW, Kaaks R.

Int J Cancer. 2018 Apr 1;142(7):1355-1360. doi: 10.1002/ijc.31164. Epub 2017 Dec 11.

3.

Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

Fortner RT, Vitonis AF, Schock H, Hüsing A, Johnson T, Fichorova RN, Fashemi T, Yamamoto HS, Tjønneland A, Hansen L, Overvad K, Boutron-Ruault MC, Kvaskoff M, Severi G, Boeing H, Trichopoulou A, Benetou V, La Vecchia C, Palli D, Sieri S, Tumino R, Matullo G, Mattiello A, Onland-Moret NC, Peeters PH, Weiderpass E, Gram IT, Jareid M, Quirós JR, Duell EJ, Sánchez MJ, Chirlaque MD, Ardanaz E, Larrañaga N, Nodin B, Brändstedt J, Idahl A, Khaw KT, Allen N, Gunter M, Johansson M, Dossus L, Merritt MA, Riboli E, Cramer DW, Kaaks R, Terry KL.

J Ovarian Res. 2017 Mar 20;10(1):20. doi: 10.1186/s13048-017-0315-6.

4.

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.

Terry KL, Schock H, Fortner RT, Hüsing A, Fichorova RN, Yamamoto HS, Vitonis AF, Johnson T, Overvad K, Tjønneland A, Boutron-Ruault MC, Mesrine S, Severi G, Dossus L, Rinaldi S, Boeing H, Benetou V, Lagiou P, Trichopoulou A, Krogh V, Kuhn E, Panico S, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Gram IT, Weiderpass E, Duell EJ, Sanchez MJ, Ardanaz E, Etxezarreta N, Navarro C, Idahl A, Lundin E, Jirström K, Manjer J, Wareham NJ, Khaw KT, Byrne KS, Travis RC, Gunter MJ, Merritt MA, Riboli E, Cramer DW, Kaaks R.

Clin Cancer Res. 2016 Sep 15;22(18):4664-75. doi: 10.1158/1078-0432.CCR-16-0316. Epub 2016 Apr 8.

5.

Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity.

Fichorova RN, Yamamoto HS, Fashemi T, Foley E, Ryan S, Beatty N, Dawood H, Hayes GR, St-Pierre G, Sato S, Singh BN.

J Biol Chem. 2016 Jan 8;291(2):998-1013. doi: 10.1074/jbc.M115.651497. Epub 2015 Nov 20.

6.

Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics.

Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):E4354-63. doi: 10.1073/pnas.1510824112. Epub 2015 Jul 20.

7.

Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.

Zalenskaya IA, Joseph T, Bavarva J, Yousefieh N, Jackson SS, Fashemi T, Yamamoto HS, Settlage R, Fichorova RN, Doncel GF.

PLoS One. 2015 Jun 8;10(6):e0128557. doi: 10.1371/journal.pone.0128557. eCollection 2015.

8.

Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract.

Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, Ismail N, Moodley A, Sabatini ME, Ghebremichael MS, Nusbaum C, Huttenhower C, Virgin HW, Ndung'u T, Dong KL, Walker BD, Fichorova RN, Kwon DS.

Immunity. 2015 May 19;42(5):965-76. doi: 10.1016/j.immuni.2015.04.019.

9.

A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation.

Fichorova RN, Mendonca K, Yamamoto HS, Murray R, Chandra N, Doncel GF.

Toxicol Appl Pharmacol. 2015 Jun 15;285(3):198-206. doi: 10.1016/j.taap.2015.02.017. Epub 2015 Mar 25.

PMID:
25818602
10.

Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.

Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM.

Am J Reprod Immunol. 2015 May;73(5):437-44. doi: 10.1111/aji.12349. Epub 2014 Dec 17.

PMID:
25521546
11.

Systemic inflammation in the extremely low gestational age newborn following maternal genitourinary infections.

Fichorova RN, Beatty N, Sassi RR, Yamamoto HS, Allred EN, Leviton A; ELGAN Investigators.

Am J Reprod Immunol. 2015 Feb;73(2):162-74. doi: 10.1111/aji.12313. Epub 2014 Aug 28.

12.

Complement activation and kidney injury molecule-1-associated proximal tubule injury in severe preeclampsia.

Burwick RM, Easter SR, Dawood HY, Yamamoto HS, Fichorova RN, Feinberg BB.

Hypertension. 2014 Oct;64(4):833-8. doi: 10.1161/HYPERTENSIONAHA.114.03456. Epub 2014 Jun 23.

PMID:
24958504
13.

Urinary intestinal fatty acid binding protein predicts necrotizing enterocolitis.

Gregory KE, Winston AB, Yamamoto HS, Dawood HY, Fashemi T, Fichorova RN, Van Marter LJ.

J Pediatr. 2014 Jun;164(6):1486-8. doi: 10.1016/j.jpeds.2014.01.057. Epub 2014 Mar 15.

14.

Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy.

Burwick RM, Fichorova RN, Dawood HY, Yamamoto HS, Feinberg BB.

Hypertension. 2013 Dec;62(6):1040-5. doi: 10.1161/HYPERTENSIONAHA.113.01420. Epub 2013 Sep 23.

PMID:
24060886
15.

Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.

Cramer DW, Williams K, Vitonis AF, Yamamoto HS, Stuebe A, Welch WR, Titus L, Fichorova RN.

Cancer Causes Control. 2013 Nov;24(11):1911-23. doi: 10.1007/s10552-013-0266-1. Epub 2013 Aug 8.

16.

The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert.

Fichorova RN, Buck OR, Yamamoto HS, Fashemi T, Dawood HY, Fashemi B, Hayes GR, Beach DH, Takagi Y, Delaney ML, Nibert ML, Singh BN, Onderdonk AB.

Sex Transm Infect. 2013 Sep;89(6):460-6. doi: 10.1136/sextrans-2013-051052. Epub 2013 Jul 31.

17.

Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide.

Yamamoto HS, Xu Q, Fichorova RN.

BMC Microbiol. 2013 Jan 8;13:4. doi: 10.1186/1471-2180-13-4.

18.

Endobiont viruses sensed by the human host - beyond conventional antiparasitic therapy.

Fichorova RN, Lee Y, Yamamoto HS, Takagi Y, Hayes GR, Goodman RP, Chepa-Lotrea X, Buck OR, Murray R, Kula T, Beach DH, Singh BN, Nibert ML.

PLoS One. 2012;7(11):e48418. doi: 10.1371/journal.pone.0048418. Epub 2012 Nov 7.

19.

Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action.

Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB, Doncel GF.

MBio. 2011 Oct 25;2(6):e00168-11. doi: 10.1128/mBio.00168-11. Print 2011.

Supplemental Content

Loading ...
Support Center